Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Core Laboratories (CLB) Stock Price & Analysis

CLB Stock Chart & Stats

No data to display
Day’s Range
N/A
52-Week Range
N/A
Previous Close
N/A
Volume
N/A
Average Volume (3M)
N/A
Market Cap
MXN 9.17B
Enterprise Value
MXN 599.81M
Total Cash (Recent Filing)
MXN 21.38M
Total Debt (Recent Filing)
MXN 161.97M
Price to Earnings (P/E)
31.3
Beta
N/A
Next Earnings
Feb 03, 2027 (Est.)
EPS Estimate
2.93
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Improved Balance Sheet

Materially lower leverage and steadily increasing equity provide a stronger capital base for Core Lab. This improves resilience through operating volatility, supports continued technology investment, and preserves flexibility to return cash while managing debt obligations.

Proprietary Technology Adoption

Successful deployment of proprietary completion and diagnostic technologies demonstrates differentiated technical capability and customer validation. The five-year contract adds recurring program support, deepens the operator relationship, and can improve revenue durability beyond individual projects.

Asset-Light Cash Model

Core Lab’s asset-light model limits the capital required to support expansion and preserve cash generation. Low recurring capital intensity can protect financial flexibility, fund technology development, and support shareholder returns when operating conditions improve.

Bears Say

Revenue And Margin Contraction

The sharp TTM revenue decline and lower gross and net margins indicate weaker operating leverage and reduced earnings power. If demand remains subdued, lower utilization and pricing pressure could constrain profitability and reduce the cash available for investment.

Geopolitical Operating Disruption

Ongoing geopolitical disruption is affecting multiple regions and directly delaying customer projects, field operations, and shipments. Prolonged interruptions could defer revenue, raise service costs, and make international activity and quarterly execution less predictable.

Uneven Cash Conversion

Improved free cash flow is encouraging, but conversion below net income and volatile operating cash flow point to inconsistent cash quality. Working-capital demands and collection timing may limit funding flexibility even when reported earnings remain positive.

Core Laboratories News

CLB FAQ

What is Core Laboratories’s market cap?
Core Laboratories’s market cap is Mex$9.17B.
When is Core Laboratories’s upcoming earnings report date?
Core Laboratories’s next earnings report is estimated for Feb 03, 2027 (not yet confirmed), which is in 93 days.
How were Core Laboratories’s earnings last quarter?
Core Laboratories released its earnings results on Oct 28, 2026. The company reported Mex$3.007 earnings per share for the quarter.
Is Core Laboratories overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Core Laboratories pay dividends?
Core Laboratories does not currently pay dividends.
What is Core Laboratories’s EPS estimate?
Core Laboratories’s EPS estimate is 2.93.
How many shares outstanding does Core Laboratories have?
Core Laboratories has 45,884,540 shares outstanding.
What happened to Core Laboratories’s price movement after its last earnings report?
Core Laboratories reported an EPS of Mex$3.007 in its last earnings report. Following the earnings report the stock price went same ―.
Which hedge fund is a major shareholder of Core Laboratories?
Hedge funds hold Core Laboratories shares: hedge funds increased their holdings by 491.4K shares last quarter.
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology